The Prevention Role of Theaflavin-3,3'-digallate in Angiotensin II Induced Pathological Cardiac Hypertrophy via CaN-NFAT Signal Pathway

Nutrients. 2022 Mar 26;14(7):1391. doi: 10.3390/nu14071391.

Abstract

Theaflavin-3,3'-digallate (TF3) is a representative theaflavin of black tea and is remarkable for the anti-coronary heart disease effect. As an adaptive response to heart failure, pathological cardiac hypertrophy (PCH) has attracted great interest. In this study, the PCH cell model was established with H9c2 cells by angiotensin II, and the prevention effect and mechanisms of TF3 were investigated. The results showed that the cell size and fetal gene mRNA level were significantly reduced as pretreated with TF3 at the concentration range of 1-10 μM, also the balance of the redox system was recovered by TF3 at the concentration of 10 μM. The intracellular Ca2+ level decreased, Calcineurin (CaN) expression was down-regulated and the p-NFATc3 expression was up-regulated. These results indicated that TF3 could inhibit the activation of the CaN-NFAT signal pathway to prevent PCH, and TF3 may be a potentially effective natural compound for PCH and heart failure.

Keywords: calcineurin; calcium ion; nuclear factor of activated T cells; oxidative stress; pathological cardiac hypertrophy; theaflavin-3,3′-digallate.

MeSH terms

  • Angiotensin II / pharmacology
  • Antioxidants / pharmacology
  • Biflavonoids* / pharmacology
  • Calcineurin
  • Cardiomegaly / chemically induced
  • Cardiomegaly / drug therapy
  • Cardiomegaly / prevention & control
  • Catechin* / analogs & derivatives
  • Catechin* / pharmacology
  • Heart Failure* / drug therapy
  • Heart Failure* / prevention & control
  • Humans
  • Myocytes, Cardiac
  • Signal Transduction

Substances

  • Antioxidants
  • Biflavonoids
  • theaflavin-3,3'-digallate
  • Angiotensin II
  • theaflavin
  • Catechin
  • Calcineurin